Research

Hormonal

Metformin is the first-line pharmacological treatment for Type 2 Diabetes, reducing HbA1c by ~1.5% and fasting glucose by ~20%, with additional cardiovascular and potential cancer-preventive benefits.

Metformin is the standard first drug for Type 2 Diabetes. It lowers blood sugar by about 1.5% and helps heart health. Common side effects like stomach upset are usually mild and go away. It is safe for kidneys if your eGFR is above 45. If your kidney function drops below 30, you should not take it.

GoodSupportsHIGH confidence
Metformin is considered the agent of first line for treatment of T2DM, in the absence of contraindications... It decreases fasting blood glucose by approximately 20% and HbA1c by 1.5%... Metformin does not have adverse cardiovascular effects, and it appears to decrease cardiovascular events... Observational data suggest that metformin decreases cancer incidence.
Juan José Marín-Peñalver et al. · World Journal of Diabetes · 2016

Why this rating

Supported by UKPDS, meta-analyses, and observational studies.

Source

Update on the treatment of type 2 diabetes mellitus

Juan José Marín-Peñalver et al. · World Journal of Diabetes · 2016

DOI 10.4239/wjd.v7.i17.354

narrative_reviewCited 653×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →